drugset / Trial / NCT01186159

The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain

NCT01186159

Phase 4 Completed 90 enrolled Xianwei Zhang Pfizer · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To investigate the dose-effect relations among the expression of COX-2 in polymorphonuclear leukocytes (PMNL) and macrophages, systemic and local inflammatory response and postoperative pain

Timeline

Start
2010-11
Primary completion
2011-06
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 20 mg Intravenous

Indications

No indication recorded.